
|Articles|October 8, 2014
- NSCLC (Issue 4)
- Volume 4
- Issue 1
The Implementation of Personalized Medicine for Lung Cancer Patients
Author(s)Vassiliki Papadimitrakopoulou, MD
Vassiliki Papadimitrakopoulou, MD, from the University of Texas MD Anderson Cancer Center, discusses the implementation of personalized medicine for lung cancer patients.
Advertisement
Vassiliki Papadimitrakopoulou, MD, Professor, Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, discusses the implementation of personalized medicine for lung cancer patients.
Articles in this issue
about 11 years ago
The Benefit of Treating Lung Cancer with Immunotherapyabout 11 years ago
The Cancer Genome Atlas Plays Role in Future Therapies for NSCLCabout 11 years ago
In Practice: Systemic Treatment for Metastatic NSCLCabout 11 years ago
The Importance of Biomarkers for Lung Cancerabout 11 years ago
Clinical Trial Profile: The OAK Studyabout 11 years ago
Optimizing of Therapeutic Sequencing Being Studied in NSCLCAdvertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5







































